Works matching DE "SITAGLIPTIN"

Results: 817

Impact of baseline alanine aminotransferase levels on the efficacy of dapagliflozin and sitagliptin: Latent class analysis from the DIVERSITY‐CVR study.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 9, p. 5099, doi. 10.1111/dom.16559

By:

Mochizuki, Kohei;
Fuchigami, Ayako;
Hirose, Takahisa;
Uchino, Hiroshi

Publication type:

Article

To compare the efficacy and safety profile of empagliflozin and sitagliptin as an add on therapy to metformin in T2DM patients.

Published in:

Professional Medical Journal, 2025, v. 32, n. 8, p. 940, doi. 10.29309/TPMJ/2025.32.08.8585

By:

Iqbal, Javed;
Hussain, Asif;
Aziz, Haroon;
Hussain, Mazhar

Publication type:

Article

Comparison of the effects of empagliflozin and sitagliptin, as an add-on to metformin, on cardio-metabolic and glycemic parameters of patients with type 2 diabetes mellitus: a randomized, double-blind clinical trial.

Published in:

BMC Research Notes, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13104-025-07214-2

By:

Mesri Alamdari, Naimeh;
Barghaman, Maryam;
Roshanravan, Neda;
Mobasseri, Majid;
Tutunchi, Helda;
Baharami, Amir;
Aliasgarzadeh, Akbar;
Sadra, Vahideh

Publication type:

Article

Formulation of sitagliptin-loaded oral polymeric nano scaffold: process parameters evaluation and enhanced anti-diabetic performance.

Published in:

Artificial Cells, Nanomedicine & Biotechnology, 2018, v. 46, p. 66, doi. 10.1080/21691401.2017.1411933

By:

Jahangir, Mohammed Asadullah;
Khan, Ruqaiyah;
Sarim Imam, Syed

Publication type:

Article

Effects of Sitagliptin on Nonalcoholic Fatty Liver Disease in Diet-Induced Obese Rats.

Published in:

Metabolic Syndrome & Related Disorders, 2013, v. 11, n. 4, p. 243, doi. 10.1089/met.2012.0128

By:

Akaslan, Selvihan Beysel;
Degertekin, Ceyla Konca;
Yilmaz, Guldal;
Cakir, Nuri;
Arslan, Metin;
Toruner, Fusun Balos

Publication type:

Article

Understanding the Molecular Dynamics of Type-2 Diabetes Drug Target DPP-4 and its Interaction with Sitagliptin and Inhibitor Diprotin-A.

Published in:

Cell Biochemistry & Biophysics, 2014, v. 70, n. 2, p. 907, doi. 10.1007/s12013-014-9998-0

By:

Chakraborty, Chiranjib;
Hsu, Minna;
Agoramoorthy, Govindasamy

Publication type:

Article

Understanding the influence of thermal cycles on the stability of metformin HCl in presence of Sitagliptin phosphate monohydrate and polyvinyl alcohol.

Published in:

Journal of Thermal Analysis & Calorimetry, 2023, v. 148, n. 23, p. 13321, doi. 10.1007/s10973-023-12639-7

By:

Malayandi, Rajkumar;
Malgave, Adarsh;
Gaikwad, Vinod;
Peraman, Ramalingam;
Aishwarya, Dande;
Ravichandiran, V.

Publication type:

Article

Sitagliptin Ameliorates Creb5/lncRNA ENSMUST00000213271-Mediated Vascular Endothelial Dysfunction in Obese Mice.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 4, p. 679, doi. 10.1007/s10557-023-07436-1

By:

Zong, Yi;
Wang, Xiaorui;
Zhang, Yi;
Tan, Na;
Zhang, Yan;
Li, Li;
Liu, Limei

Publication type:

Article

Sitagliptin Protects Cardiac Function by Reducing Nitroxidative Stress and Promoting Autophagy in Zucker Diabetic Fatty (ZDF) Rats.

Published in:

Cardiovascular Drugs & Therapy, 2018, v. 32, n. 6, p. 541, doi. 10.1007/s10557-018-6831-9

By:

Zhou, Yi;
Wang, Huanyuan;
Man, Fuli;
Guo, Zhiying;
Xu, Jiahui;
Yan, Wenjing;
Li, Jiaying;
Pan, Qi;
Wang, Wen

Publication type:

Article

Effect of Anagliptin and Sitagliptin in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: What Is the Real REASON Behind It?

Published in:

Cardiovascular Drugs & Therapy, 2018, v. 32, n. 3, p. 311, doi. 10.1007/s10557-018-6779-9

By:

Jonnalagadda, Venu Gopal;
Char, Harish Prabhanna;
Ankana, Praveen Kumar

Publication type:

Article

Sitagliptin Is More Effective Than Gliclazide in Preventing Pro-Fibrotic and Pro-Inflammatory Changes in a Rodent Model of Diet-Induced Non-Alcoholic Fatty Liver Disease.

Published in:

Molecules, 2022, v. 27, n. 3, p. 727, doi. 10.3390/molecules27030727

By:

Ren, Jing;
Wang, Xiaoyu;
Yee, Christine;
Gorrell, Mark D.;
McLennan, Susan V.;
Twigg, Stephen M.

Publication type:

Article

Practical Asymmetric Synthesis of Sitagliptin Phosphate Monohydrate.

Published in:

Molecules, 2018, v. 23, n. 6, p. 1440, doi. 10.3390/molecules23061440

By:

Gao, Haoling;
Yu, Jiangang;
Ge, Chengsheng;
Jiang, Qun

Publication type:

Article

Attenuating Hypoxia-Induced Apoptosis and Autophagy of Mesenchymal Stem Cells: the Potential of Sitagliptin in Stem Cell-Based Therapy.

Published in:

Cellular Physiology & Biochemistry (Karger AG), 2015, v. 37, n. 5, p. 1914, doi. 10.1159/000438552

By:

Wang, Xi-Mei;
Yang, Yue-Jin;
Wu, Yong-Jian;
Zhang, Qian;
Qian, Hai-Yan

Publication type:

Article

Exploring the Anticancer and Antioxidant Potential Effects of Sitagliptin: An In Vitro Study on Lung Cancer Cell Lines.

Published in:

Magazine of Al-Kufa University for Biology, 2024, v. 16, n. 2, p. 15, doi. 10.36320/ajb/v16.i2.16101

By:

Al Khafaji, Ameer M.;
Bairam, Ahsan F.;
Abbas, Shaymaa F.

Publication type:

Article

The effect of select systemic medications on outcomes in diabetics with central retinal vein occlusion.

Published in:

Therapeutic Advances in Ophthalmology, 2022, p. 1, doi. 10.1177/25158414211063076

By:

Simmons, Kirsten;
Singh, Pali;
Borkar, Durga S.;
Birnbaum, Faith;
Thomas, Akshay S.;
Fekrat, Sharon

Publication type:

Article

Simultaneous HPLC determination of remdesivir and dexamethasone in the presence of metformin, sitagliptin, and glimepiride in a synthetic mixture and spiked human plasma.

Published in:

Pharmacia (0428-0296), 2024, v. 71, n. 1, p. 1, doi. 10.3897/pharmacia.71.e120463

By:

Bozhanov, Stanislav;
Smerikarova, Miglena;
Maslarska, Vania

Publication type:

Article

Kidney protective effect of sitagliptin in 5-fluorouracil-challenged rats.

Published in:

Pharmacia (0428-0296), 2024, v. 71, n. 1, p. 1, doi. 10.3897/pharmacia.71.e114441

By:

Al-Ghamdi, Ahmed Hassan;
Mohamed, Mervat Z.;
Elbadry, Rabei M.;
Fouad, Amr A.

Publication type:

Article

西格列汀联合预混胰岛素治疗脆性糖尿病伴高脂血症疗效和安全性的回顾性研究

Published in:

Journal of Pharmaceutical Practice & Service, 2018, v. 36, n. 5, p. 468, doi. 10.3969/j.issn.1006-0111.2018.05.020

By:

薛梅萍;
郑茹萍;
林惠娥;
甘惠贞

Publication type:

Article

Lipid management in patients with type 2 diabetes and effects of gender‐affirming therapy.

Published in:

2024

By:

Stringer, Felicity;
Cooke, Ryan;
MacIsaac, Richard;
Teng, Jessie

Publication type:

Case Study

Repurposing Anti-diabetic Drugs to Cripple Quorum Sensing in Pseudomonas aeruginosa.

Published in:

Microorganisms, 2020, v. 8, n. 9, p. 1285, doi. 10.3390/microorganisms8091285

By:

Hegazy, Wael A. H.;
Khayat, Maan T.;
Ibrahim, Tarek S.;
Nassar, Majed S.;
Bakhrebah, Muhammed A.;
Abdulaal, Wesam H.;
Alhakamy, Nabil A.;
Bendary, Mahmoud M.

Publication type:

Article

Common ABCB1 SNP, C3435T could affect systemic exposure of dapagliflozin in healthy subject.

Published in:

Translational & Clinical Pharmacology, 2022, v. 30, n. 4, p. 212, doi. 10.12793/tcp.2022.30.e23

By:

Jun Gi Hwang;
Sae Im Jeong;
Yu Kyong Kim;
Yujin Lee;
Sang Chun Ji;
SeungHwan Lee;
Min Kyu Park

Publication type:

Article

Comparação indireta entre dapagliflozina, sitagliptina e saxagliptina para o tratamento de pacientes com diabetes mellitus tipo 2, inadequadamente controlados com metformina.

Published in:

JBES: Brazilian Journal of Health Economics / Jornal Brasileiro de Economia da Saúde, 2013, v. 5, n. 3, p. 154

By:

Clark, Otavio;
Borges, Luiza;
Minowa, Eimy;
Farhat, Cecilia;
Bernardino, Graziela;
Monteiro, Roberta;
Eugenio Barbieri, Douglas

Publication type:

Article

DPP-4 Inhibitor Sitagliptin Improves Cardiac Function and Glucose Homeostasis and Ameliorates β-Cell Dysfunction Together with Reducing S6K1 Activation and IRS-1 and IRS-2 Degradation in Obesity Female Mice.

Published in:

Journal of Diabetes Research, 2018, p. 1, doi. 10.1155/2018/3641516

By:

Qiao, Shigang;
Mao, Guofang;
Li, Hua;
Ma, Zhimin;
Hong, Lei;
Zhang, Huiling;
Wang, Chen;
An, Jianzhong

Publication type:

Article

A Physiologically‐Based Quantitative Systems Pharmacology Model of the Incretin Hormones GLP‐1 and GIP and the DPP4 Inhibitor Sitagliptin.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2020, v. 9, n. 6, p. 353, doi. 10.1002/psp4.12520

By:

Balazki, Pavel;
Schaller, Stephan;
Eissing, Thomas;
Lehr, Thorsten

Publication type:

Article

A Validated HPLC-PDA Method for Simultaneous Quantitation of Four Oral Antidiabetic Drugs and Application to Pharmaceutical Preparations.

Published in:

Journal of the Chemical Society of Pakistan, 2018, v. 40, n. 3, p. 495

By:

AlShehri, Mona;
Al Zoman, Nourah;
AlHarbi, Hend;
AlSulaihim, Kholod;
AlOdaib, Faten

Publication type:

Article

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus.

Published in:

Geriatrics & Gerontology International, 2018, v. 18, n. 4, p. 631, doi. 10.1111/ggi.13235

By:

Tago, Motoko;
Oyama, Jun‐ichi;
Sakamoto, Yoshiko;
Shiraki, Aya;
Uchida, Fumi;
Chihara, Atsuko;
Ikeda, Hideo;
Kuroki, Shigetaka;
Gondo, Shigeki;
Iwamoto, Taketo;
Uchida, Yasufumi;
Node, Koichi

Publication type:

Article

Comparison of charges and resource use associated with saxagliptin and sitagliptin.

Published in:

Health Economics Review, 2016, v. 6, n. 1, p. 1, doi. 10.1186/s13561-016-0104-8

By:

Vaidya, Varun;
Adhikari, Keyuri;
Sheehan, Jack;
Kalsekar, Iftekhar

Publication type:

Article

Sitagliptin and fucoidan prevent apoptosis and reducing ER stress in diabetic rat testes.

Published in:

Andrologia, 2021, v. 53, n. 3, p. 1, doi. 10.1111/and.13858

By:

Kizilay, Gulnur;
Ersoy, Onur;
Cerkezkayabekir, Aysegul;
Topcu‐Tarladacalisir, Yeter

Publication type:

Article

Sitagliptin protects male albino rats with testicular ischaemia/reperfusion damage: Modulation of VCAM‐1 and VEGF‐A.

Published in:

Andrologia, 2020, v. 52, n. 2, p. 1, doi. 10.1111/and.13472

By:

Abdel‐Aziz, Asmaa Mohamed;
Naguib Abdel Hafez, Sara Mohammed

Publication type:

Article

Ertugliflozin: First Global Approval.

Published in:

Drugs, 2018, v. 78, n. 4, p. 513, doi. 10.1007/s40265-018-0878-6

By:

Markham, Anthony

Publication type:

Article

Sitagliptin: A Review in Type 2 Diabetes.

Published in:

Drugs, 2017, v. 77, n. 2, p. 209, doi. 10.1007/s40265-016-0686-9

By:

Scott, Lesley

Publication type:

Article

Sitagliptin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus.

Published in:

2014

By:

Plosker, Greg

Publication type:

Journal Article

Analytical method development and validation for simultaneous estimation of Ipragliflozin and Sitagliptin in tablet form by RP-HPLC method.

Published in:

International Journal of Pharmacy & Life Sciences, 2018, v. 9, n. 7, p. 5860

By:

Nizami, Tahir;
Shrivastava, Birendra;
Sharma, Pankaj

Publication type:

Article

Evaluation of dipeptidyl peptidase-4 enzyme inhibition by some commonly used gliptins on cutaneous wound healing in albino rats.

Published in:

National Journal of Physiology, Pharmacy & Pharmacology, 2017, v. 7, n. 12, p. 1359, doi. 10.5455/njppp.2017.7.0832224082017

By:

K., Chandrashekar;
Y. R., Rajashekar;
R., Ganesan

Publication type:

Article

Biocatalytic Cascade for Synthesis of Sitagliptin Intermediate Employing Coupled Transaminase.

Published in:

Biotechnology & Bioprocess Engineering, 2023, v. 28, n. 2, p. 300, doi. 10.1007/s12257-023-0085-5

By:

Khobragade, Taresh P.;
Pagar, Amol D.;
Giri, Pritam;
Sarak, Sharad;
Jeon, Hyunwoo;
Joo, Sangwoo;
Goh, Younghwan;
Park, Bu-Soo;
Yun, Hyungdon

Publication type:

Article

Treatment patterns of drug-naive patients with type 2 diabetes mellitus: a retrospective cohort study using a Japanese hospital database.

Published in:

Diabetology & Metabolic Syndrome, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13098-019-0486-y

By:

Morita, Yohei;
Murayama, Hiroki;
Odawara, Masato;
Bauer, Melissa

Publication type:

Article

فراوانی عوارض دارویی و اپیزودهای هیپوگلیسمی در بیماران دیابتی نوع ۲ تحت درمان با داروهای نوین مراجعه کننده به بیمارستان امام خمینی ارومیه.

Published in:

Arak Medical University Journal, 2025, v. 28, n. 1, p. 43, doi. 10.61186/jams.28.1.43

By:

ابراهیم محمدی;
لعیا هوشمند;
آرش معصومی

Publication type:

Article

Study on Synergistic Effect of Bromocriptine and Sitagliptin in Streptozotocin-induced Diabetic Rats.

Published in:

Journal of Clinical & Diagnostic Research, 2021, v. 15, n. 4, p. 14, doi. 10.7860/JCDR/2021/47643.14799

By:

NILESHRAJ, GOVINDARAJ;
SWITHRAA, CHANDRASEKARAN;
SAKTHIBALAN, MURUGESAN;
SAWADKAR, MARUTI SHRIPATI

Publication type:

Article

Can Antidiabetic Medications Affect Telomere Length in Patients with Type 2 Diabetes? A Mini-Review.

Published in:

Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2023, v. 16, p. 3739, doi. 10.2147/DMSO.S428560

By:

Qin, Baoding

Publication type:

Article

Genome-Wide Transcriptome Analysis in Type 2 Diabetes Patients Treated by Sitagliptin.

Published in:

Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2022, v. 15, p. 1761, doi. 10.2147/DMSO.S334144

By:

Ma, Rui;
Deng, Xiao-long;
Aleteng, Qi-qi-ge;
Li, Lei;
Zhu, Jun

Publication type:

Article

Effect of Anagliptin versus Sitagliptin on Renal Function: Subanalyzes from the REASON Trial.

Published in:

Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2022, v. 15, p. 685, doi. 10.2147/DMSO.S350518

By:

Teragawa, Hiroki;
Morimoto, Takeshi;
Fujii, Yuichi;
Ueda, Tomohiro;
Sakuma, Mio;
Shimabukuro, Michio;
Arasaki, Osamu;
Node, Koichi;
Nomiyama, Takashi;
Ueda, Shinichiro

Publication type:

Article

A Clinical Study on the Association of Sodium-Glucose Cotransporter 2 Inhibitors and Acute Kidney Injury Among Diabetic Chinese Population.

Published in:

Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2021, v. 14, p. 1621, doi. 10.2147/DMSO.S300494

By:

Shen, Lianglan;
Yang, Hongli;
Fang, Xingxing;
Huang, Huaxing;
Yao, Wubin;
Chen, Dongmei;
Shen, Yan

Publication type:

Article

Comparison Between Pioglitazone/Metformin Combination Therapy and Sitagliptin/Metformin Combination Therapy on the Efficacy in Chinese Type 2 Diabetic Adults Insufficiently Controlled with Metformin: Study Protocol of an Open-Label, Multicenter, Non-Inferiority Parallel-Group Randomized Controlled Trial

Published in:

Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2021, v. 14, p. 1243, doi. 10.2147/DMSO.S293307

By:

Zhang, Fang;
Tang, Lizhi;
Li, Jing;
Yan, Zhe;
Li, Juan;
Tong, Nanwei

Publication type:

Article

Effect of Anagliptin versus Sitagliptin on Inflammatory Markers: Sub-Analysis from the REASON Trial.

Published in:

Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2020, v. 13, p. 4993, doi. 10.2147/DMSO.S282968

By:

Teragawa, Hiroki;
Morimoto, Takeshi;
Fujii, Yuichi;
Ueda, Tomohiro;
Sakuma, Mio;
Shimabukuro, Michio;
Arasaki, Osamu;
Node, Koichi;
Nomiyama, Takashi;
Ueda, Shinichiro

Publication type:

Article

Sitagliptin Increases Beta-Cell Function and Decreases Insulin Resistance in Newly Diagnosed Vietnamese Patients with Type 2 Diabetes Mellitus.

Published in:

Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2020, v. 13, p. 2119, doi. 10.2147/DMSO.S255071

By:

Le, Tuan Dinh;
Nguyen, Nga Thi Phi;
Nguyen, Son Tien;
Tran, Hoa Thi Thanh;
Nguyen, Lan Thi Ho;
Duong, Hoang Huy;
Nguyen, Ha Manh;
Do, Binh Nhu

Publication type:

Article

Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway.

Published in:

Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2017, v. 10, p. 207, doi. 10.2147/DMSO.S132537

By:

Civantos, Esther;
Bosch, Enrique;
Ramirez, Elisa;
Zhenyukh, Olha;
Egido, Jesús;
Lorenzo, Oscar;
Mas, Sebastián

Publication type:

Article

Fixed-dose combinations in type 2 diabetes - role of the canagliflozin metformin combination.

Published in:

Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2015, v. 8, p. 287, doi. 10.2147/DMSO.S69282

By:

Fleming, Joshua W.;
Fleming, Laurie W.;
Davis, Courtney S.

Publication type:

Article

Comparison of extended release GLP-1 receptor agonist therapy versus sitagliptin in the management of type 2 diabetes.

Published in:

Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2013, v. 6, p. 435, doi. 10.2147/DMSO.S48837

By:

Stolar, Mark W.;
Grimm, Michael;
Chen, Steve

Publication type:

Article

Renal Replacement Therapy for Metformin and Sitagliptin Overdose.

Published in:

Ibnosina Journal of Medicine & Biomedical Sciences, 2018, v. 10, n. 2, p. 68, doi. 10.4103/ijmbs.ijmbs_72_17

By:

Chaaban, Ahmad;
Gebran, Nicole;
El Houni, Ali;
Alamri, Khuloud;
Bernieh, Bassam

Publication type:

Article

Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials program.

Published in:

Clinical Trials, 2019, v. 16, n. 3, p. 253, doi. 10.1177/1740774519836766

By:

Shavadia, Jay S;
Sharma, Abhinav;
Gu, Xiangqiong;
Neaton, James;
DeLeve, Laurie;
Holmes, David;
Home, Phillip;
Eckel, Robert H;
Watkins, Paul B;
Granger, Christopher B

Publication type:

Article